Sean Sheridan is a vice president in the Intellectual Property Practice at CRA. He provides economic consulting services for litigation and has worked on engagements for a wide range of industries and products, including pharmaceuticals, recombinant therapeutic proteins, vaccines, gene editing, medical devices, diagnostics, research tools, electronic health records, and many others outside of the life sciences. Previously, Sean was as an assistant director at the technology transfer office at the University of Chicago where he was responsible for managing the intellectual property strategy for a broad range of technologies and was frequently required to assess the value of new discoveries and potential products. He is a frequent speaker and instructor on intellectual property valuation, and also publishes on related topics. Sean has been named to the IAM Patent 1000: The World’s Leading Patent Professionals (economic experts) every year since 2019.
